Boundless Bio, Inc.
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -74.79% | -5.20% | 7.16% | 11.46% | 0.53% |
| Total Depreciation and Amortization | 342.61% | -7.49% | -0.97% | -2.21% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 484.52% | 13.84% | 7.40% | -16.01% | -1.09% |
| Change in Net Operating Assets | -164.85% | -529.36% | -55.01% | 7.95% | 284.57% |
| Cash from Operations | -40.08% | -48.13% | 0.86% | 13.81% | 18.59% |
| Capital Expenditure | -375.00% | 98.11% | -2,726.67% | 68.75% | 18.64% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 58.33% | 8.96% | 27.66% | -7.47% | 263.58% |
| Cash from Investing | 58.15% | 12.46% | 23.79% | -7.21% | 269.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -100.00% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 663.64% | -113.33% | 920.49% | 167.38% | 96.34% |